Inventor · disambiguated record
Dale A. Rudolph
Also filed as: RUDOLPH DALE A
27 granted patents·10 pending applications·126 citations·filing 2001–2023
96Inventor score
Files withJANSSEN PHARMACEUTICA NV22CHAI WENYING3BONAVENTURE PASCAL2BRANSTETTER BRYAN JAMES2CARRUTHERS NICHOLAS I2
Top patents by PatentIndex Score
37 records- 0194US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0293US10617676B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 14, 2020·12 cites·27 claims
- 0392US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0492US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0590US9586962B2Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulatorsLETAVIC MICHAEL A·Filed 2012·Granted Mar 7, 2017·12 cites·14 claims
- 0690US9540388B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jan 10, 2017·5 cites·35 claims
- 0789US11207298B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·2 cites·32 claims
- 0888US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 0987US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 1085USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 1184US8680275B2Fused heterocyclic compounds as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Mar 25, 2014·9 cites·20 claims
- 1284US6951882B2Substituted 4-phenyl-[1,3]-dioxanesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Oct 4, 2005·17 cites·44 claims
- 1382US7579470B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 25, 2009·3 cites·2 claims
- 1481US2023338341A1SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1579US8883808B2Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapyBONAVENTURE PASCAL·Filed 2006·Granted Nov 11, 2014·8 cites·15 claims
- 1678US8618288B2Pyrimidine compounds as serotonin receptor modulatorsDVORAK CURT A·Filed 2009·Granted Dec 31, 2013·3 cites·4 claims
- 1775US11759455B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 19, 2023·0 cites·25 claims
- 1873US9096596B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 4, 2015·1 cites·22 claims
- 1973US8183239B2Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptorBONAVENTURE PASCAL·Filed 2006·Granted May 22, 2012·2 cites·35 claims
- 2072US9062044B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsBRANSTETTER BRYAN JAMES·Filed 2010·Granted Jun 23, 2015·2 cites·18 claims
- 2171US7402680B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Jul 22, 2008·4 cites·21 claims
- 2268US7897771B2Fused heterocyclic compoundsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Mar 1, 2011·0 cites·2 claims
- 2367US12338243B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 24, 2025·0 cites·23 claims
- 2467US9102686B25,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 11, 2015·0 cites·30 claims
- 2565US7317025B2Non-peptidic NPY Y2 receptor inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jan 8, 2008·2 cites·10 claims
- 2663US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2762US9604982B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Mar 28, 2017·0 cites·22 claims
- 2860US10323032B2P2X7 ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jun 18, 2019·0 cites·1 claims
- 2958US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 3056US2017174680A1P2x7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 3155US10053462B2P2X7 modulatorsJansssen Pharmaceutica NV·Filed 2016·Granted Aug 21, 2018·0 cites·6 claims
- 3254US2008132540A1Non-peptidic npy y2 receptor inhibitorsCARRUTHERS NICHOLAS I·Filed 2007·Application pending·0 cites
- 3352US2011040088A1Fused heterocyclic compoundsCARRUTHERS NICHOLAS I·Filed 2010·Application pending·0 cites
- 3447US2012129870A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 3547US2012015957A1Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptorCHAI WENYING·Filed 2008·Application pending·0 cites
- 3639US2018118749A1P2x7 modulatorsJansssen Pharmaceutica NV·Filed 2015·Application pending·0 cites
- 3735US2001051632A1Phenyl-substituted indolizines and tetrahydroindolizinesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dale A. Rudolph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →